Brain-derived neurotrophic factor gene Val66Met polymorphism modulates reversible cerebral vasoconstriction syndromes

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Chen, Shih Pin ^a,b   Fuh, Jong Ling ^a,b   Wang, Shuu Jiun ^a,b   Tsai, Shih Jen ^a,b   Hong, Chen Jee ^a,b   Yang, Albert C ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; METHIONINE; VALINE;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; BRAIN BLOOD FLOW; CEREBROVASCULAR DISEASE; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DISEASE SEVERITY; DNA POLYMORPHISM; ETHNICITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY; PROSPECTIVE STUDY; REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME; AMINO ACID SUBSTITUTION; BRAIN; DEMOGRAPHY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; SINGLE NUCLEOTIDE POLYMORPHISM; STENOSIS, OCCLUSION AND OBSTRUCTION; SYNDROME; VASCULARIZATION; VASOCONSTRICTION;

AMINO ACID SUBSTITUTION; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CONSTRICTION, PATHOLOGIC; DEMOGRAPHY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRODUCIBILITY OF RESULTS; SYNDROME; VASOCONSTRICTION;

EID: 79952792151     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018024     Document Type: Article

References (27)

1. Calabrese LH, Dodick DW, Schwedt TJ, Singhal AB, (2007) Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med 146: 34-44.
2. Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, et al. (2007) The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain 130: 3091-3101.
3. Chen SP, Fuh JL, Lirng JF, Chang FC, Wang SJ, (2006) Recurrent primary thunderclap headache and benign CNS angiopathy: spectra of the same disorder? Neurology 67: 2164-2169.
4. Chen SP, Fuh JL, Wang SJ, Chang FC, Lirng JF, et al. (2010) Magnetic resonance angiography in reversible cerebral vasoconstriction syndromes. Ann Neurol 67: 648-656.
5. Chen SP, Fuh JL, Chang FC, Lirng JF, Shia BC, et al. (2008) Transcranial color doppler study for reversible cerebral vasoconstriction syndromes. Ann Neurol 63: 751-757.
6. Kumar S, Goddeau RP Jr, Selim MH, Thomas A, Schlaug G, et al. (2010) Atraumatic convexal subarachnoid hemorrhage: clinical presentation, imaging patterns, and etiologies. Neurology 74: 893-899.
7. Pezet S, Malcangio M, (2004) Brain-derived neurotrophic factor as a drug target for CNS disorders. Expert Opin Ther Targets 8: 391-399.
8. Arévalo JC, Wu SH, (2006) Neurotrophin signaling: many exciting surprises! Cell Mol Life Sci 63: 1523-1537.
9. Huang EJ, Reichardt LF, (2001) Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24: 677-736.
10. Kermani P, Hempstead B, (2007) Brain-derived neurotrophic factor: a newly described mediator of angiogenesis. Trends Cardiovasc Med 17: 140-143.
11. Wang S, Bray P, McCaffrey T, March K, Hempstead BL, et al. (2000) p75(NTR) mediates neurotrophin-induced apoptosis of vascular smooth muscle cells. Am J Pathol 157: 1247-1258.
12. Yang B, Slonimsky JD, Birren SJ, (2002) A rapid switch in sympathetic neurotransmitter release properties mediated by the p75 receptor. Nat Neurosci 5: 539-545.
13. Slonimsky JD, Yang B, Hinterneder JM, Nokes EB, Birren SJ, (2003) BDNF and CNTF regulate cholinergic properties of sympathetic neurons through independent mechanisms. Mol Cell Neurosci 23: 648-660.
14. Kasselman LJ, Sideris A, Bruno C, Perez WR, Cai N, et al. (2006) BDNF: a missing link between sympathetic dysfunction and inflammatory disease? J Neuroimmunol 175: 118-127.
15. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, et al. (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112: 257-269.
16. Jiang H, Wang R, Liu Y, Zhang Y, Chen ZY, (2009) BDNF Val66Met polymorphism is associated with unstable angina. Clin Chim Acta 400: 3-7.
17. Headache Classification Subcommittee of the International Headache Society (2004) The International Classification of Headache Disorders: 2nd edition. Cephalalgia 24 (Suppl 1): 9-160.
18. Hong CJ, Yu YW, Lin CH, Tsai SJ, (2003) An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients. Neurosci Lett 349: 206-208.
19. Picard RR, Berk KN, (1990) Data splitting. Am Stat 44: 140-147.
20. Chanock SJ, Manolio T, Boehnke M, Boerwinkle E, Hunter DJ, et al. (2007) Replicating genotype-phenotype associations. Nature 447: 655-660.
21. Petryshen TL, Sabeti PC, Aldinger KA, Fry B, Fan JB, et al. (2010) Population genetic study of the brain-derived neurotrophic factor (BDNF) gene. Mol Psychiatry 15: 810-815.
22. Croll SD, Wiegand SJ, Anderson KD, Lindsay RM, Nawa H, (1994) Regulation of neuropeptides in adult rat forebrain by the neurotrophins BDNF and NGF. Eur J Neurosci 6: 1343-1353.
23. Zukowska Z, Pons J, Lee EW, Li L, (2003) Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system? Can J Physiol Pharmacol 81: 89-94.
24. Dodick DW, (2002) Thunderclap headache. J Neurol Neurosurg Psychiatry 72: 6-11.
25. Springer J, Wagner S, Subramamiam A, McGregor GP, Groneberg DA, et al. (2004) BDNF-overexpression regulates the reactivity of small pulmonary arteries to neurokinin A. Regul Pept 118: 19-23.
26. Terracciano A, Martin B, Ansari D, Tanaka T, Ferrucci L, et al. (2010) Plasma BDNF concentration, Val66Met genetic variant and depression-related personality traits. Genes Brain Behav 9: 512-518.
27. Luo KR, Hong CJ, Liou YJ, Hou SJ, Huang YH, et al. (2010) Differential regulation of neurotrophin S100B and BDNF in two rat models of depression. Prog Neuropsychopharmacol Biol Psychiatry 34: 1433-1439.